Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356*

(Received for publication, December 20, 1996, and in revised form, May 16, 1997)

Linh Nguyen ab, Marina Holgado-Madruga cd, Christiane Maroun ae, Elizabeth D. Fixman af, Darren Kamikura ag, Tanya Fournier abh, Alain Charest gh, Michel L. Tremblay hi, Albert J. Wong cd and Morag Park ahjk

From the Departments of a Medicine, j Oncology, and h Biochemistry, Molecular Oncology Group, Royal Victoria Hospital, McGill University, 687 Pine Ave. West, Montreal, Quebec, Canada H3A 1A1 and the Departments of c Microbiology & Immunology and d Pharmacology, Kimmel Cancer Institute, Philadelphia, Pennsylvania 19107

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

Hepatocyte growth factor/scatter factor is a multifunctional factor that induces mitogenesis, motility, invasion, and branching tubulogenesis of several epithelial and endothelial cell lines in culture. The receptor for hepatocyte growth factor has been identified as the Met-tyrosine kinase. Upon stimulation with hepatocyte growth factor, the Met beta  subunit becomes highly phosphorylated on tyrosine residues, one of which, tyrosine 1356 within the carboxyl terminus, is crucial for dissociation, motility, and branching tubule formation in Madin-Darby canine kidney epithelial cells. Tyrosine 1356 forms a multisubstrate binding site for the Grb2 and Shc adaptor proteins, the p85 subunit of phosphatidylinositol 3'-kinase, phospholipase Cgamma , and a phosphatase, SHP2. To investigate additional signaling molecules that are activated by the Met receptor, we have identified hepatocyte growth factor-induced phosphoproteins in tubular epithelial cells. We have established that proteins of 100-130 kDa are highly phosphorylated following stimulation of epithelial cells and that one of these is the Grb2-associated binding protein Gab1, a possible insulin receptor substrate-1-like signal transducer. We show that Gab1 is the major substrate for the Met kinase in vitro and in vivo. Association of Gab1 with Met requires a functional Grb2 binding site involving tyrosine 1356 and to a lesser extent tyrosine 1349. Met receptor mutants that fail to induce branching tubulogenesis are impaired in their ability to interact with Gab1, suggesting that Gab1 may play a role in these processes.


INTRODUCTION

Hepatocyte growth factor or scatter factor (HGF)1 is a mesenchymally derived factor with pleiotropic activities on epithelial cells. HGF stimulates mitogenesis, motility, and invasiveness of epithelial cells and induces branching tubulogenesis of kidney, breast, and lung epithelium grown in matrix culture (1). In vivo, HGF is a potent angiogenic factor (2) and is involved in organ regeneration (3) and tumorigenesis (4). HGF is essential during embryogenesis (5, 6) and is a prototype for a family of growth modulators that share structural similarity with the serine protease plasminogen but lack proteolytic activity (7, 8).

A high affinity receptor for HGF has been identified as the Met-tyrosine kinase (9, 10), which was originally identified as an oncogene, Tpr-Met (11). The Met receptor is synthesized as a 170-kDa precursor that undergoes glycosylation, proteolytic cleavage, and disulfide bond formation to yield a mature 190-kDa heterodimeric molecule consisting of a 40-kDa alpha  and a 145-kDa beta  subunit (12). The beta  subunit spans the plasma membrane, and its cytoplasmic portion contains a catalytic kinase domain as well as several potential sites of tyrosine phosphorylation (13, 14). Using receptor chimeras, we and others have demonstrated that the Met receptor cytoplasmic domain is sufficient to mediate the pleiotropic biological responses to HGF in epithelial cells (15-17) and that these events require Met-dependent protein tyrosine phosphorylation (18, 19).

Phosphorylated tyrosine residues in the non-catalytic cytoplasmic domains of receptor-tyrosine kinases act as specific binding sites for Src homology 2 (SH2) and phosphotyrosine binding (PTB) domain-containing proteins, which in turn transmit intracellular signals (reviewed in Ref. 20). Although signaling pathways downstream from receptor-tyrosine kinases that are involved in a mitogenic response have been characterized in detail, little is known of the signaling pathways involved in cell dissociation, motility, and morphogenesis. Upon stimulation with HGF, the Met beta  subunit becomes highly phosphorylated on tyrosine residues (10, 21), and from structure-function analyses, tyrosine residues within the carboxyl terminus are crucial for biological activity. The Met carboxyl terminus contains 3 tyrosine residues (Tyr-1349, Tyr-1356, and Tyr-1365) (22), two of which (Tyr-1349 and Tyr-1356) are highly conserved between other members of the Met receptor-tyrosine kinase gene family, Sea and Ron (23). Tyrosine 1356 within the carboxyl terminus is crucial for dissociation, motility, and branching tubule formation in Madin-Darby canine kidney epithelial cells (MDCK) (15, 19). The amino acid sequence downstream from tyrosine 1356 is VNV, which represents a consensus binding site for several SH2 domain-containing substrates (24, 25). Consistent with this, tyrosine 1356 forms a multisubstrate binding site for the Grb2 adaptor protein, the p85 subunit of PI 3-kinase, phospholipase Cgamma , and SHP2 (18, 23, 26, 27), and together with tyrosine 1349 is required for association and/or phosphorylation of the Shc adaptor protein (28, 29). Cells expressing a Met receptor mutant that fails to associate with the Grb2 adaptor protein (N1358H), yet retains the ability to interact with other substrates, scatter in response to HGF but fail to form branching tubules, suggesting that Grb2-dependent signaling pathways may be involved in the morphogenic activities of HGF (27).

To investigate the signaling molecules that are activated by the Met receptor, we have identified HGF-induced phosphoproteins in MDCK cells. We have established that proteins of 100-130 kDa are highly phosphorylated following HGF stimulation of MDCK cells and that one of these is the Grb2-associated binding protein Gab1, a possible insulin receptor substrate-1 (IRS-1)-like signal transducer. We show that Gab1 is the major substrate for the Met kinase and that efficient association of Gab1 requires a functional Grb2 binding site involving Tyr-1356 in the Met carboxyl terminus. Met receptor mutants that fail to induce branching morphogenesis are impaired in their ability to interact with Gab1 suggesting that Gab1 may play a role in these processes.


EXPERIMENTAL PROCEDURES

Antibodies

Monoclonal anti-phosphotyrosine PY20 and RC20H were obtained from Transduction Laboratories (Lexington, KY), and 4G10 was obtained from Upstate Biotechnology Inc. (Lake Placid, NY). Rabbit polyclonal antibodies which recognize the human Met receptor or Tpr-Met protein were generated against a carboxyl-terminal peptide of the human Met protein as described previously (Ab 143) (14).

Cell Culture

MDCK cells were obtained from Dr. Michael Stoker, COS-1 cells from Dr. Gordon Wong, and all other cell lines were obtained from the American Type Tissue Culture Collection. All cell lines were maintained in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum. MDCK cells overexpressing human HGF receptor were generated by retroviral infection.

HGF Stimulation of MDCK Cells

MDCK cells were seeded at 1 million per 100-mm dish. The next day, cells were washed with DMEM and serum-starved for 24 h in 6 ml of DMEM containing 0.02% FBS. HGF, purified as described elsewhere (15), was then added at 100 units/ml for the time indicated. Cells were immediately lysed in 1 ml of cold buffer A, and whole cell lysates were prepared as described below.

Whole Cell Extracts

Cells were harvested in lysis buffer A, containing 50 mM Hepes, pH 7.4, 0.15 M NaCl, 10% glycerol, 0.1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 2 µg/ml aprotinin, 2 µg/ml leupeptin, 1 mM Na3VO4, 1 mM NaF. Alternatively, tissues were homogenized with a Polytron in buffer A. Lysates were obtained by an extraction of solubilized proteins on ice for 30 min, followed by centrifugation at 12,000 × g for 15 min. Protein concentrations were determined by the method of Bradford (47).

Transient Transfections

Generation of the wild-type and mutant Tpr-Met or colony-stimulating factor-Met cDNAs has been described elsewhere (15, 20, 26, 30). 6 µg of each DNA was transfected into COS-1 cells (1 × 106) by a standard DEAE-dextran precipitation method as described (14). Alternatively, 293T cells (8 × 105) were transfected with 5 µg of expression plasmid DNA encoding either wild-type or mutant forms of the Met receptor plus 5 µg of hemagglutinin-tagged Gab1 expression plasmid by calcium phosphate coprecipitation. Cells were maintained in DMEM/10% FBS and lysed in 1 ml of lysis buffer A 48 h post-transfection.

In Vitro Association/Kinase Assay

Association assays were performed as described elsewhere (26). Briefly, Tpr-Met proteins from COS cell lysates (100 µl) were immunoprecipitated with 1.5 µl of rabbit polyclonal Met antiserum (Ab 143) (14). Immune complexes were collected with protein A-Sepharose washed three times with buffer A, and Tpr-Met proteins were activated by an incubation in 50 µl of kinase buffer containing 50 mM Hepes, pH 7.4, 10 mM MnCl2, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 50 µM ATP for 30 min at room temperature. Tpr-Met and associated complexes were washed three times with buffer A and lysates (1 mg of protein) from various serum-starved cell lines were added for 3 h at 4 °C with gentle agitation. Complexes were washed three times with buffer A, once with kinase buffer, and phosphorylation of bound proteins was performed in kinase buffer containing 10-15 µCi of [gamma -32P]ATP with or without 50 µM cold ATP as indicated. Phosphorylated proteins were then resolved by SDS-polyacrylamide gel electrophoresis and visualized by autoradiography.

Glutathione S-Transferase Fusion Proteins

The plasmids containing the cDNAs encoding different mutant GST-Grb2 fusion proteins were transformed into the DH5alpha Escherichia coli strain. Fusion proteins were produced by induction with isopropyl-1-thio-beta -D-galactopyranoside and affinity-purified with glutathione-Sepharose beads (Pharmacia) as described (31). GST fusion proteins (1-3 µg) immobilized on Sepharose were incubated with 0.5 ml of MDCK cell lysates (1 mg) for 3 h at 4 °C with rocking. Bound proteins were washed three times with buffer A and eluted twice with 250 µl of 10 mM glutathione in buffer A for 15 min at 4 °C. The combined eluates were then used in the in vitro association assay as described above.

Immunoprecipitation and Western Blotting

Cell lysates (0.1-0.5 ml) were incubated with appropriate antibodies for 1 h at 4 °C with gentle agitation. Volumes were adjusted to 0.5 ml with buffer A. The immune complexes were collected with protein A-Sepharose, washed with buffer A, and resolved by PAGE. The proteins were transferred to a nitrocellulose membrane (Schleicher and Schuell), blocked for 1 h with TBST (10 mM Tris-Cl, pH 7.4, 2.5 mM EDTA, 150 mM NaCl, 0.1% Tween 20) containing 3% bovine serum albumin at room temperature and incubated with the appropriate antibody for 1 h at room temperature. Bound antibodies were revealed with horseradish peroxidase-linked protein A, and the signals were visualized with an enhanced chemiluminescence (ECL) detection system (Amersham).

Far Western Analysis

For Far Western analysis, wild-type and mutant Tpr-Met proteins obtained from transient transfection of COS-1 cells (1/5 plate) were immunoprecipitated with anti-Met sera (anti-144), separated by SDS-PAGE, and transferred to nitrocellulose. GST fusion proteins generated as described above were purified on glutathione-Sepharose. Far Western blots were incubated with 2.5 µg ml-1 GST fusion protein for 3 h, followed by anti-GST antibody (Santa Cruz Biotechnology) and then secondary antibody (goat anti-mouse IgG). Bound antibodies were revealed with horseradish peroxidase-linked protein A, and the signals were visualized with an ECL detection system (Amersham).

Phosphoamino Acid Analysis

Radiolabeled phosphoproteins were visualized by autoradiography, excised from the polyacrylamide gel, and subjected to hydrolysis in 6 N HCl for 90 min at 110 °C. Liberated phosphoamino acids were then resolved by two-dimensional thin layer electrophoresis (32) and identified by the staining of internal phosphotyrosine/serine/threonine standards with ninhydrin.

V8 Protease Digestion

Radiolabeled phosphoproteins were resolved on a 10% polyacrylamide gel, located by autoradiography, excised, and subjected to in situ Staphylococcus aureus V8 protease digestion by the method of Cleveland et al. (33). Briefly, 2 µg of V8 protease was added per well, and the digestion was carried out for 30 min in the stacking gel at room temperature. Phosphopeptides were separated in a resolving 10% polyacrylamide gel and visualized by autoradiography.


RESULTS

HGF-induced Tyrosine Phosphorylation of Proteins in MDCK Cells

To identify signaling pathways that mediate the pleiotropic actions of HGF in epithelial cells, we have characterized HGF-induced tyrosine phosphorylation of proteins in MDCK cells. MDCK cells dissociate and scatter in response to HGF and form branching tubules when suspended in a three-dimensional matrix. Total cellular proteins from cell lysates prepared from untreated and HGF-stimulated MDCK cells were immunoprecipitated and immunoblotted with monoclonal antiphosphotyrosine antibodies (PY20). Following stimulation of MDCK cells with HGF for 2 min, multiple tyrosine-phosphorylated proteins were detected (Fig. 1A). A protein of 145 kDa, corresponding in size to the Met receptor, was phosphorylated at low levels, whereas the predominant tyrosine-phosphorylated proteins migrated with molecular mass of 110-130 kDa (Fig. 1A). The level of phosphorylation of these proteins remained high for at least 15 min. To establish whether the 145-kDa protein was the Met receptor, MDCK cells overexpressing the Met receptor were stimulated with HGF, and proteins were immunoprecipitated with monoclonal anti-phosphotyrosine antibodies (4G10) and immunoblotted with either anti-phosphotyrosine (4G10) or anti-Met sera (Ab 143) (12) (Fig. 1B). Following stimulation with HGF, an increase in tyrosine phosphorylation of a protein of 145 kDa was detected (Fig. 1B, lanes 1 and 2) that corresponded to the beta  subunit of the Met receptor (Fig. 1B, lanes 3 and 4).


Fig. 1. HGF stimulates tyrosyl phosphorylation of cellular proteins in MDCK cells. MDCK cells were serum-starved in DMEM supplemented with 0.02% FBS for 24 h and subsequently stimulated with HGF (100 units/ml) for the times indicated. A, total cellular proteins from cell lysates prepared from untreated and HGF-stimulated MDCK cells were resolved on an 8% SDS-PAGE, transferred to nitrocellulose membrane, and immunoblotted with monoclonal antiphosphotyrosine antibodies (PY20). B, MDCK cells untreated and HGF-stimulated were solubilized in lysis buffer A (see "Experimental Procedures") by scraping. Proteins from whole cell lysates from one plate were immunoprecipitated with monoclonal antiphosphotyrosine antibody (4G10), resolved on an 8% SDS-PAGE, transferred to nitrocellulose membrane, and blotted with antiphosphotyrosine (4G10) or polyclonal anti-Met receptor antibodies (Ab 143). Molecular mass markers and the position of the 145-kDa beta -chain of the Met receptor are indicated.
[View Larger Version of this Image (24K GIF file)]

In Vitro Association Assays Identify Met Substrates of 100 and 130 kDa in MDCK Cells

To identify whether any of the phosphoproteins in MDCK cells associate with the Met receptor kinase we have used an in vitro association assay. In vitro association assays have been used in studies of other receptor-tyrosine kinases to detect protein-protein interactions that are difficult to detect using metabolic labeling of tissue culture cells (34). We have shown that the oncogenic counterpart of the Met receptor (Tpr-Met) is a constitutively activated kinase that trans/autophosphorylates on the same tyrosine residues as those found in the Met receptor (18, 30). Consistent with this, Tpr-Met associates with and activates the same substrates and signaling pathways as the full-length receptor (18, 26, 27, 29). Using this approach, two proteins of 100 and 130 kDa from MDCK cell lysates were found to associate in vitro with either Tpr-Met or an activated Met receptor (data not shown) and become phosphorylated in the presence of [gamma -32P]ATP (Fig. 2A). We thus took advantage of the ability of Tpr-Met to be activated in an HGF-independent manner to use in vitro association assays. The interaction between Tpr-Met or Met (data not shown) and the p100 and p130 proteins was dependent on an active Met kinase, since a Tpr-Met mutant (K1108A) that contains a lysine to alanine substitution in the phosphotransfer domain is kinase-inactive and failed to phosphorylate and/or associate with both the p100 and p130 proteins (Fig. 2A, lanes 2 and 3). The intensity of phosphorylation of p100 and p130 was unaltered following alkali treatment which preferentially hydrolyzes phosphoserine and phosphothreonine residues (35), consistent with these proteins being phosphorylated on tyrosine residues (data not shown). To investigate this possibility, phosphoamino acid analysis was performed on the p100/130 proteins isolated from the polyacrylamide gel in Fig. 2A (lane 2). This analysis showed only the presence of phosphotyrosine (Fig. 2B) demonstrating that the p100/130 proteins are not phosphorylated by a serine/threonine kinase, but directly by a tyrosine kinase in the in vitro assays. Thus, since Tpr-Met is the only kinase activity detected in these assays by autophosphorylation, we concluded that the p100/130 proteins are substrates for the Met kinase.


Fig. 2. Proteins of 100 and 130 kDa from MDCK cells associate with and are phosphorylated by an activated Met protein. A, wild-type and mutant Met proteins from transiently transfected COS-1 cells were immunoprecipitated with polyclonal anti-Met antibodies (Ab 143) and activated following phosphorylation with cold ATP. Extracts from serum-starved MDCK cells (lanes 2 and 3) or an equivalent volume of lysis buffer (lane 1) were then added. To visualize protein associated with an activated Met protein, complexes were washed several times with buffer A (see "Experimental Procedures") and then incubated in kinase buffer with [gamma -32P]ATP. Complexes were resolved by an 8% SDS-PAGE and visualized by autoradiography. B, the p100/130 from panel A (lane 2) were excised and submitted to phosphoamino acid analysis as described under "Experimental Procedures." Phosphoamino acids were resolved by two-dimensional thin layer electrophoresis and visualized by autoradiography.
[View Larger Version of this Image (24K GIF file)]

The p100 and p130 Phosphoproteins Are Related

To determine if the p100 and p130 proteins were unique to MDCK epithelial cells we investigated whether similar proteins were detected using the in vitro association kinase assay in cell lysates prepared from other cell lines and tissues. Phosphorylated proteins of molecular masses ranging from 100 to 120 kDa were identified in extracts from human placenta tissue, a human carcinoma cell line (HeLa), and a monkey kidney cell line (COS-1) as well as from mouse kidney, lung, and whole embryo tissues (Fig. 3A). To establish whether these proteins were related, radiolabeled phosphoproteins of 100-130 kDa in mass were excised from the gel and subjected to partial V8 protease mapping. A similar pattern of V8 protease-digested phophopeptides was obtained from the p100 and p130 proteins expressed in MDCK cells, suggesting that they are related proteins (Fig. 3B, lanes 4 and 5). Moreover, the patterns of phosphopeptides obtained for the 100-120-kDa proteins expressed in human placenta, HeLa (Fig. 3B, lanes 1 and 6), and COS-1 cells (data not shown) were similar to that obtained from the p100 and p130 proteins from MDCK cells. Although p100/130 proteins from murine tissues (kidney and lung) gave a pattern distinct from that of MDCK cell proteins, interspecies differences at the primary amino acid level make V8 protease mapping limited in the comparison of proteins between different species. Nevertheless, under identical conditions of digestion, our results suggest that the 100-130-kDa phosphoproteins identified in the in vitro association assay from MDCK, HeLa, and COS cells, as well as human placental tissue bear structural homology.


Fig. 3. Proteins of 100-130 kDa from various cell lines and tissues associate with and are phosphorylated by an activated Met protein. Wild-type Met proteins from transiently transfected COS-1 cells were immunoprecipitated with polyclonal anti-Met antibodies (Ab 143) and activated following phosphorylation with cold ATP, and protein extracts (1-2 mg) from various cell lines or tissues were added. To visualize proteins associated with an activated Met, complexes were washed several times with buffer A and then incubated in kinase buffer with [gamma -32P]ATP. Complexes were resolved by an 8% SDS-PAGE and visualized by autoradiography. B, phosphoproteins from panel B with molecular mass ranging from 100 to 130 kDa were excised from the wet gel and submitted to proteolytic digestion with V8 S. aureus. Phosphopeptides were separated on a 10% polyacrylamide gel and subjected to autoradiography.
[View Larger Version of this Image (34K GIF file)]

A Functional Grb2 Binding Site in the Met Receptor Is Required for Association with p100/130

The carboxyl terminus of the Met receptor contains three tyrosine residues, Tyr-1349, Tyr-1356, and Tyr-1365, two of which (Tyr-1349 and Tyr-1356) are highly conserved between members of the Met receptor subfamily, Sea and Ron (23). To determine if the interaction and phosphorylation of the p110/130 proteins was dependent on specific tyrosine residue(s) in Met we have used mutant Tpr-Met proteins containing substitutions of phenylalanine for tyrosine at positions 1349, 1356, 1365, or 1349/1356 in the Met receptor carboxyl terminus. When compared with the wild-type Tpr-Met protein, the Y1365F and Y1349F mutants showed slightly reduced levels of association/phosphorylation with the p100/130 proteins (55 and 65%, respectively) (Fig. 4, A and D, lanes 1, 3, and 7). In contrast, the Y1356F mutant showed a significant reduction in association/phosphorylation of the p100/130 proteins to 10% that of the wild-type levels, and the double mutant Y1349F/Y1356F failed to associate with or phosphorylate the p100/130 proteins (Fig. 4, A and D, lanes 1, 4, and 6). The ability of the p100/130 proteins to associate with or be phosphorylated by the Y1356F or Y1349F/Y1356F mutant proteins showed no correlation with their in vitro kinase activity which was 80 and 72% of wild type, respectively (Fig. 4D). This suggested that Tyr-1356 was critical for the efficient association of Tpr-Met with the p100/130 proteins. Moreover, the absence of association with the Y1349F/Y1356F mutant suggests that Tyr-1349 in addition to Tyr-1356 is required for full association with the p100/130 proteins.


Fig. 4. The p100/130 proteins require tyrosine 1349 and 1356 for association with Met. A, wild-type Met (lane 1) or various Met mutant proteins (lanes 2-7) from transiently transfected COS-1 cells were immunoprecipitated with anti-Met sera (Ab 143) and activated by phosphorylation with ATP. Extracts (1 mg of protein) from serum-starved MDCK cells were then added. To visualize proteins associated with activated Met proteins, complexes were washed several times with buffer A and then incubated in kinase buffer with [gamma -32P]ATP. Complexes were resolved by an 8% SDS-PAGE and visualized by autoradiography. B and C, the ability of each Met mutant in A to associate with the Grb2 or Shc adaptor proteins was detected by immunoblot analysis with anti-Grb2 serum (B) or with anti-Shc serum (C). D, the percentage phosphorylation of the p100/130 proteins by Tpr-Met mutants and the kinase activity of the various Tpr-Met mutants is indicated as a histogram. Values are an average of three independent experiments.
[View Larger Version of this Image (36K GIF file)]

The amino acid sequence downstream from Tyr-1356 (VNV) represents a consensus binding site for multiple SH2 domain-containing substrates including the Grb2 adaptor protein (24, 25). In addition to binding Grb2, Tyr-1356 together with Tyr-1349 forms a multisubstrate binding site for the p85 subunit of PI 3-kinase, SHP2, phospholipase Cgamma , and the Shc adaptor protein (23, 29). Significantly, a Met mutant (N1358H), which has selectively lost the ability to bind Grb2 (Fig. 4B, lane 5) while retaining wild type levels of in vitro kinase activity (Fig. 4D) and the ability to bind Shc (Fig. 4C, lane 5) PI 3-kinase, SHP2, and phospholipase Cgamma in the in vitro association assay (27, 29) showed a decreased ability to associate with the p100/130 proteins, similar to that of the Y1356F mutant (Fig. 4A, lanes 4 and 5). These data suggest that since both the Y1356F and N1358H mutants fail to associate with Grb2, the majority of the p100/130 proteins may be recruited to Met via the Grb2 adaptor protein. Alternatively, the asparagine two amino acids downstream from Tyr-1356 may be required for the direct binding of the p100/130 proteins.

The Grb2 Adaptor Protein Mediates Association of p100/130 with Met

To establish if the p100/130 proteins interacted with Grb2, we used a GST-Grb2 fusion protein to identify Grb2-associating proteins from MDCK lysates. GST or GST-Grb2 fusion proteins were first adsorbed to glutathione-Sepharose beads, then incubated with lysates prepared from serum-starved MDCK cells. The GST or GST-Grb2 and associated proteins were eluted from the Sepharose with glutathione and tested for their ability to be associated with and phosphorylated by Tpr-Met. Phosphorylation of the p100/130 proteins from MDCK cells required the presence of Tpr-Met and was observed in "pull down" assays containing GST-Grb2 (Fig. 5A, lanes 3 and 4) but not in those containing GST alone (Fig. 5A, lane 2).


Fig. 5. The p100/130 proteins interact with the carboxyl-terminal SH3 domain of Grb2. A, GST or a GST-Grb2 fusion protein (1-3 µg) was immobilized on Sepharose beads and incubated with lysates (1 mg of protein) prepared from serum-starved MDCK cells. Bound proteins were washed with lysis buffer A and eluted in the same buffer containing 10 mM glutathione. MDCK cell proteins eluted with GST or GST-Grb2 fusion proteins were then associated with an activated Tpr-Met protein. Complexes were washed, and associated proteins were phosphorylated in the presence of [gamma -32P]ATP, resolved on an 8% SDS-PAGE, and visualized by autoradiography. B, lysates from serum-starved MDCK cells were associated with GST (lane 1), GST-Grb2 (lane 2), or GST fusion proteins containing the Grb2 SH2 (lane 3), Grb2 amino-terminal (N)-SH3-SH2 (lane 4), or Grb2 SH2-SH3-(C) carboxyl-terminal (lane 5) domains. GST fusion and associated proteins were eluted with glutathione and subjected to an association/kinase assay with activated Tpr-Met as described in A. Proteins were resolved on an 8% SDS-PAGE and visualized by autoradiography.
[View Larger Version of this Image (28K GIF file)]

These data suggest that Grb2 may act as an adaptor protein to recruit the p100/130 proteins to the Met kinase where they are subsequently phosphorylated directly by Tpr-Met. To determine the domain(s) of Grb2 required for the interaction with the p100/130 proteins, GST fusion proteins containing the SH2 domain of Grb2 with the amino- or carboxyl-terminal SH3 domains of Grb2 were used in pull down assays to isolate proteins from MDCK cells. Proteins that associated with the full-length Grb2 or fusion proteins containing the SH2, NH2-SH3-SH2, or SH2-SH3-COOH domains of Grb2 were subjected to phosphorylation by Tpr-Met as described above (Fig. 5B). The Grb2 carboxyl-terminal SH3 was required for association with the p100/130 proteins and subsequent phosphorylation by Tpr-Met. Fusion proteins containing either the Grb2 SH2 domain or the amino-terminal SH3-SH2 domain were insufficient (Fig. 5B, lanes 3 and 4). These results are consistent with a model where the carboxyl-terminal SH3 domain of Grb2 associates with the p100/130 proteins and the Grb2 SH2 domain recruits these proteins to a phosphorylated Tyr-1356 in the carboxyl terminus of the Met receptor.

The p100/130 in MDCK Cells Are Immunologically Related to Gab1

A novel Grb2-binding protein of 115 kDa, Gab1 (Grb2-associated binder-1), was recently isolated by screening a cDNA expression library prepared from a human glial tumor cell line with a GST-Grb2 fusion protein (36). Gab1 is phosphorylated following stimulation of cells with EGF or insulin and is thought to function as a multisubstrate docking protein, with the ability to couple to other signaling pathways in a manner similar to IRS-1 (36). To investigate whether the p100/130 Grb2-binding proteins expressed in MDCK cells and the p120 Met-associated protein from HeLa cells corresponded to Gab1, we performed Met in vitro association assays with lysates prepared from serum-starved MDCK and HeLa cells and subjected half of each association to an in vitro kinase assay in the presence of 50 µM ATP and blotted for Gab1. Gab1 immunoreactive proteins of 95 and 115 kDa from MDCK cells and 110 kDa from HeLa cells associated with the wild-type Tpr-Met protein (Fig. 6A, lanes 1 and 3). In each case, an increase in mobility of 5-10 kDa was observed when proteins were phosphorylated by Tpr-Met with ATP (Fig. 6A, compare lanes 2 and 4 with 1 and 3) and are consistent with the size of the p100/130 and p120 Met-associated proteins detected in MDCK cells and HeLa cells, respectively (Fig. 3).


Fig. 6. Gab1 associates with and is phosphorylated by Met in vitro. A, lysates prepared from serum-starved HeLa and MDCK cells were incubated with wild-type Met protein from transiently transfected COS-1 cells that had been immunoprecipitated and activated by phosphorylation with ATP. Half of each association was washed several times with buffer A and then incubated in kinase buffer with ATP. Complexes were resolved by an 8% SDS-PAGE transferred to nitrocellulose membrane and immunoblotted with Gab1 sera. B, depletion of Gab1 from an MDCK cell lysate. Cell lysates from serum-starved MDCK cells were incubated with protein A-Sepharose (lane 1) or anti-Gab1 serum overnight (lane 2), and bound proteins were then resolved by 8% SDS-PAGE and immunoblotted with anti-Gab1 sera. The position of Gab1 is indicated. The immunodepleted lysates were incubated with wild-type Met protein from transiently transfected COS-1 cells that had been immunoprecipitated and activated by phosphorylation in the presence of ATP. To visualize proteins associated with an activated Met, complexes were washed several times with buffer A (see "Experimental Procedures") and then incubated in kinase buffer with [gamma -32P]ATP. Complexes were resolved by 8% SDS-PAGE and visualized by autoradiography. C, wild-type Tpr-Met (lane 1) or Tpr-Met mutant proteins (lanes 2-6) from transiently transfected COS-1 cells were immunoprecipitated and activated by phosphorylation with cold ATP. Protein extracts from serum-starved MDCK cells (500 µg of protein) were added and incubated for 1 h. Complexes were washed three times with buffer A (see "Experimental Procedures") resolved by 8% SDS-PAGE, and immunoblotted with anti-Gab1 serum. D, wild-type Tpr-Met (lane 1) or Tpr-Met mutant proteins (lanes 2-6) from transiently transfected COS-1 cells were immunoprecipitated, resolved by 10% SDS-PAGE, and transferred to nitrocellulose. Far Western blots were incubated with 2.5 µg ml-1 GST fusion protein, followed by anti-GST antibody (Santa Cruz Biotechnology) and then secondary antibody (goat anti-mouse IgG). Bound antibodies were revealed with horseradish peroxidase-linked protein A, and the signals were visualized with an ECL detection system (Amersham) (Grb2, 40-s exposure; Gab1, 4-min exposure).
[View Larger Version of this Image (41K GIF file)]

To establish whether the p100/130 proteins in MDCK cells corresponded to Gab1, cell lysates prepared from MDCK cells were immunodepleted with anti-Gab1 antibodies prior to the in vitro association assay. No p100/130 proteins were detected in the in vitro association assay in the MDCK cell lysate depleted of Gab1 (Fig. 6B, lanes 2 and 4), whereas abundant p100/130 proteins were detected in the protein A-Sepharose-treated lysate (Fig. 6B, lanes 1 and 3) providing evidence that the p100/130 proteins from MDCK cells that associate with and are phosphorylated by Tpr-Met corresponded to Gab1. To determine if the level and specificity of binding of the p95 and p115 Gab1 immunoreactive proteins in MDCK cells (Fig. 6A) correlated with the association and phosphorylation of the p100/130 proteins (Fig. 4B) we performed the in vitro association assay with the various Tpr-Met mutants in the absence of the in vitro kinase assay and immunoblotted with anti-Gab1 sera. Gab1 immunoreactive proteins from MDCK cells associated with the wild-type Tpr-Met and Y1349F mutant proteins (Fig. 6C, lanes 1 and 3), whereas less Gab1 associated with the Y1356F and N1358H mutants, and neither protein was associated with the Y1349F/Y1356F double mutant (Fig. 6C, lanes 4-6). These results suggest that the majority of Gab1 associated with Met either directly through the Grb2 adaptor protein or required an asparagine residue two amino acids downstream from Tyr-1356. Recently an interaction between Gab1 and Met was detected using the yeast two-hybrid system suggesting that Gab1 can bind Met directly (37). To examine whether the direct association of Gab1 with Met requires the asparagine residue downstream from Tyr-1356 in a manner similar to the Grb2 adaptor protein, wild-type Met and mutant proteins were transferred to nitrocellulose and blotted with either a GST-Gab1 fusion protein (amino acids 203-689) or a GST-Grb2 fusion protein. The GST-Grb2 fusion protein which associates with Tyr-1356 in Met (26) bound to both the wild-type and the Y1349F mutant Met protein (Fig. 6D, lanes 1 and 3), whereas the GST-Gab1 fusion protein bound only to immobilized wild-type Met protein and not with any of the mutant proteins (Fig. 6D, lane 1), even though similar levels of Met proteins are present.

Gab1 Is a Physiological Substrate for the Met Receptor

To examine if Gab1 is a physiological substrate for the Met receptor-tyrosine kinase, phosphotyrosine-containing proteins were immunoprecipitated from HGF-stimulated MDCK cell lysates with anti-phosphotyrosine antibodies and immunoblotted with anti-Gab1 sera. While no Gab1 was detected prior to HGF stimulation (Fig. 7A, lane 1), a smear of Gab1 immunoreactive proteins of 100-130 kDa were detected by 2 min following stimulation of MDCK cells with HGF (Fig. 7A, lanes 2-5). To determine if Gab-1 associates with the Met receptor in vivo, hemagglutinin-tagged Gab1 was transiently coexpressed with wild-type or mutant Met receptors, which have a high basal level of kinase activity when overexpressed in 293T cells (23). Immunoprecipitation of Gab1 with anti-hemagglutinin antibody followed by immunoblotting with anti-Met sera revealed that similar levels of wild-type and Y1349F mutant Met proteins coimmunoprecipitated with Gab1, whereas little Y1356F or N1358H and no Y1349F/Y1356F mutant proteins coimmunoprecipitated with Gab1 (Fig. 7B). Thus association of Gab1 with Met in vivo paralleled that of Gab1 association with Met in vitro.


Fig. 7. Gab1 associates with Met in vivo and is phosphorylated following HGF stimulation of MDCK cells. A, MDCK cells were serum-starved in DMEM supplemented with 0.02% FBS for 24 h and subsequently stimulated with HGF (100 units/ml) for the times indicated. Cells were solubilized in lysis buffer A (see "Experimental Procedures") by scraping. Proteins from whole cell lysates from one plate were immunoprecipitated with monoclonal antiphosphotyrosine antibodies (4G10). Proteins in immune complexes were resolved by 8% SDS-PAGE and immunoblotted with anti-Gab1 sera. B, lysates from 293T cells transiently transfected with expression plasmids encoding either wild-type or mutant forms of the Met receptor, and hemagglutinin-tagged Gab1 were immunoprecipitated with anti-hemagglutinin antibody, resolved by 8% SDS-PAGE, and immunoblotted with anti-Met antibody or anti-Gab1 antibody.
[View Larger Version of this Image (29K GIF file)]


DISCUSSION

HGF is a multifunctional factor that stimulates growth, scatter, and branching tubulogenesis of epithelial cells in culture. These responses are mediated through the Met receptor tyrosine kinase. To identify novel signaling pathways that are activated by HGF, we examined the increase in tyrosine phosphorylation of proteins following stimulation of epithelial MDCK cells with HGF. We have established that proteins of 100-130 kDa are highly phosphorylated following stimulation of epithelial cells and that one of these is the Grb2-associated binding protein, Gab1.

Gab1 shows the greatest sequence similarity with IRS-1, a major substrate of the insulin receptor (38). IRS-1 and related members IRS-2 (39) and DOS (daughter of sevenless) (40, 41) constitute a new family of multisubstrate docking proteins. These proteins have in common with Gab1 an amino-terminal pleckstrin homology domain that may play a role in subcellular localization or substrate recognition (42), in addition to multiple tyrosine residues that may act to recruit SH2 or PTB domain-containing substrates. Gab1 is tyrosine-phosphorylated following stimulation of cells with insulin or EGF (36). Thus Gab1 may be a target for several protein-tyrosine kinases and in a manner similar to IRS-1, function as a multisubstrate docking protein. However, unlike IRS-1, Gab1 does not contain an SH2 or PTB binding domain, and the mechanism by which Gab1 interacts with the EGF or insulin receptor-tyrosine kinases is unknown.

In an attempt to identify substrates from epithelial MDCK cells that associated with and were phosphorylated by the Met receptor, we have used an in vitro association assay (34). Using this assay, we showed that two proteins of 100 and 130 kDa are the predominant substrates from epithelial MDCK cells (Fig. 1, A and B) that associated with and are phosphorylated by the Met receptor kinase (Fig. 2A). The association of the p100/130 proteins with the Met receptor required Met kinase activity (Fig. 2A) and was primarily dependent on phosphorylation of tyrosine 1356 and to a lesser extent tyrosine 1349 (Fig. 4A). This is consistent with previous data showing that tyrosine 1356 in the carboxyl terminus of the Met receptor acts as a multisubstrate binding site and is critical for the association of Grb2, the p85 subunit of PI 3-kinase, phospholipase Cgamma , and SHP2 and together with tyrosine 1349 is required for phosphorylation of the Shc adaptor protein (23, 26, 29). Significantly, a mutant Met protein (N1358H) that abolishes only Grb2 binding, yet retains the ability to associate with the p85 subunit of PI 3-kinase, phospholipase Cgamma , SHP2, and Shc (27) showed a similar large reduction in association/phosphorylation of the p100/130 proteins to 10% that of the wild type level (Fig. 4, A and D). This suggested that the majority of the p100/130 proteins associated with Met either indirectly through the Grb2 adaptor protein or required an asparagine residue two amino acids downstream from Tyr-1356. Consistent with the former, the p100/130 proteins from serum-starved MDCK cells, associated with a GST-Grb2 fusion protein containing the carboxyl-terminal SH3 domain of Grb2, permitting the SH2 domain of Grb2 to couple this complex to Tyr-1356 in the Met receptor (Fig. 5A).

Recently, Gab1 was identified as a novel Grb2-associated protein. We show that Gab1 immunoreactive proteins of 95 and 115 kDa from serum-starved MDCK cells or of 110 kDa from serum-starved HeLa cells associated with an activated Met kinase in vitro (Fig. 6A). In a manner similar to the p100/130 proteins, the Gab1 proteins in MDCK cells required Tyr-1349 in addition to a functional Grb2 binding site downstream from Tyr-1356 for efficient association with the Met receptor (compare Figs. 4A and 6C). Moreover, phosphorylation of Gab1 in the in vitro kinase assay produced a shift in mobility of Gab1, from proteins of 95 and 115 kDa in MDCK cells, to a diffuse 100-130-kDa species, and of the 110-kDa protein in HeLa cells to a 120-kDa species, demonstrating that Gab1 is a direct substrate for the Met kinase (Fig. 6A). Significantly, when an MDCK cell lysate is depleted of Gab1, with anti-Gab1 sera, no p100/130 proteins were detected in the in vitro association kinase assay, demonstrating that the p100/130 proteins from MDCK cells are Gab1 (Fig. 6B). Consistent with Gab1 being a downstream target in the Met signaling pathway, Gab1 was rapidly tyrosine-phosphorylated and associated with tyrosine-phosphorylated proteins following stimulation of MDCK cells with HGF (Fig. 7A) and coimmunoprecipitates with the Met receptor in vivo (Fig. 7B).

We show here that the Grb2 adaptor protein couples Gab1 with the Met receptor and in the absence of Grb2 or a Grb2 binding site, little Gab1 can associate with Met (Figs. 4A, 5A, 6C, 7B, and 8). However, only upon loss of Grb2 binding in conjunction with a Y1349F mutation did Gab1 fail to associate with Met (Figs. 4A, 6C, and 7B). Thus in addition to a functional Grb2 binding site downstream from Tyr-1356, full association of Gab1 with the Met receptor required Tyr-1349. While this paper was in preparation an interaction between Gab1 and Met was detected using the yeast two-hybrid system (37), suggesting that Gab1 bound Met directly. This interaction was dependent predominantly on Tyr-1349 and to a lesser extent on Tyr-1356 and was localized to a domain in Gab1 involving amino acids 450-532 (37). Consistent with this, a Gab1 fusion protein binds wild-type Met but not mutant proteins by Far Western analysis (Fig. 6D), suggesting that the direct association of Gab1 with Met may prefer both Tyr-1349 and Tyr-1356 in Met. Since direct binding of Gab1 with Tyr-1349 or Tyr-1356 is detected in the yeast two-hybrid system and Gab1 associates with the Met Y1356F and N1358H mutants that fail to bind Grb2 (Figs. 6C and 7B), a direct interaction between Gab1 and Met can also occur in vivo in the absence of Grb2 (Fig. 8D). However, although a direct interaction predominates in the yeast two-hybrid system, only 10% of Gab1 present in a cell lysate is recruited to Tyr-1349 in vitro (Figs. 4A and 6C) or in vivo (Fig. 7B) demonstrating that the majority of Gab1 is recruited to Tyr-1356 in an activated Met receptor via Grb2 (Figs. 4A, 6C, 7B, and 8C).


Fig. 8. Model for association of Gab1 with Met. A and B, after activation of the Met receptor-tyrosine kinase, Tyr-1356 is phosphorylated and acts to recruit a Grb2-Gab1 complex via binding of the Grb2 adaptor protein SH2 domain to a consensus binding sequence downstream from Tyr-1356 (YVNV). The associated complex may be stabilized through an additional Gab1-mediated interaction with a phosphorylated Tyr-1349 residue. C, a Y1349F mutant retains high levels of association with Gab1 (55% of wild type) mediated through a Tyr-1356-Grb2-Gab1 interaction. D, a Y1356F mutant associates at a low level with Gab1 (10% of wild type) through a possible direct association of Gab1 with a phosphorylated Tyr-1349.
[View Larger Version of this Image (14K GIF file)]

We have previously shown that Met receptor mutants that fail to induce branching morphogenesis fail to interact with Grb2 yet still activate Ras-dependent pathways, presumably mediated through a Shc-Grb2-SOS complex (27). Thus, Grb2-dependent pathways that are distinct from Ras are implicated in the formation of branching tubules in response to HGF. Interestingly, overexpression of Gab1 in MDCK cells promotes the formation of branching tubules in matrix culture in the absence of HGF, demonstrating that Gab1 is a Met-dependent substrate that contributes to morphogenesis (37). Moreover, the overexpression of a fusion protein containing the Met binding domain of Gab1 blocked HGF-induced cell dissociation (37). Since this fusion protein also contained the proline-rich domains of Gab1 predicted to associate with Grb2 (36), this domain would be predicted to compete with cellular proteins for binding to the Grb2 SH3 domain and act as a dominant negative domain for Grb2-dependent signaling. These data are therefore still consistent with the requirement for a functional Grb2 binding site in the Met receptor for branching morphogenesis (27). Furthermore, since a Y1349F mutant Met protein still retained the ability to induce branching tubules when expressed in MDCK cells (19, 27), this suggests that the Grb2-mediated association of Gab1 with Met detected here may be of greater physiological significance for branching morphogenesis.

Gab1 is a multisubstrate docking protein that, following stimulation of cells with EGF, associates with PI 3-kinase, SHP2, and phospholipase Cgamma and thus may act to amplify or coordinate signals downstream from receptor-tyrosine kinases (36). PI 3-kinase activity is required for dissociation, motility, and branching morphogenesis of epithelial cells in matrix culture following stimulation with HGF (43, 44) and thus may be a critical Gab1-regulated pathway required for branching morphogenesis. Although Gab1 is a substrate for the EGF receptor (36), EGF does not stimulate branching morphogenesis in MDCK cells which have abundant EGF receptors (45, 46). Thus, it is critical to evaluate which Met-regulated Gab1-mediated signals are required for branching morphogenesis of epithelial cells and if these are modulated in distinct spacial or temporal manners downstream from receptor-tyrosine kinases resulting in different biological responses.


FOOTNOTES

*   This research was supported by operating grants from the National Cancer Institute of Canada (to M. P.), the Medical Research Institute of Canada (to M. L. T.), and Operating Grants CA69495 and NS34514 from the National Institutes of Health (to A. J. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
b   Recipient of a Royal Victoria Hospital Research Institute fellowship.
e   Recipient of a fellowship from the Medical Research Council of Canada.
f   Recipient of a Fonds de la Recherche en Santé du Québec fellowship.
g   Recipient of a Steve Fonyo Research studentship.
i   Scholar of the Fonds de la Recherche en Santé du Québec.
k   Senior Scholar of the National Cancer Institute of Canada. To whom correspondence should be addressed. Tel.: 514-842-1231 (Ext. 5845); Fax: 514-843-1478; E-mail: morag{at}lan1.molonc.mcgill.ca.
1   The abbreviations used are: HGF/SF, hepatocyte growth factor/scatter factor; SH2, Src homology domain 2; PTB, phosphotyrosine binding domain; PI 3-kinase, phosphatidylinositol 3'-kinase; PAGE, polyacrylamide gel electrophoresis; GST, glutathione S-transferase; EGF, epidermal growth factor; IRS-1, insulin receptor substrate-1; MDCK, Madin-Darby canine kidney; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum.

REFERENCES

  1. Rosen, E. M., Nigam, S. K., and Goldberg, I. D. (1994) J. Cell Biol. 127, 1783-1787 [Abstract]
  2. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., and Rosen, E. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1937-1941 [Abstract]
  3. Matsumoto, K., and Nakamura, T. (1993) in Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-Met Receptor (Goldberg, I. D., and Rosen, E. M., eds), pp. 226-248, Birkhauser Verlag, Basel
  4. Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., and Vande Woude, G. F. (1992) Mol. Cell. Biol. 12, 5152-5158 [Abstract]
  5. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. (1995) Nature 373, 699-702 [CrossRef][Medline] [Order article via Infotrieve]
  6. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., and Kimura, N. (1995) Nature 373, 702-705 [CrossRef][Medline] [Order article via Infotrieve]
  7. Lokker, N. A., Mark, M. R., Luis, E. A., Benneth, G. L., Robbins, K. A., Baker, J. B., and Godowski, P. J. (1992) EMBO J. 11, 2503-2510 [Abstract]
  8. Hartmann, G., Naldini, L., Weidner, K. M., Sachs, M., Vigna, E., Comoglio, P. M., and Birchmeier, W. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11574-11578 [Abstract]
  9. Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R., Michalopoulos, G. A., Birchmeier, W., and Comoglio, P. M. (1991) EMBO J. 10, 2867-2878 [Abstract]
  10. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A.-L., Kmiecik, T. E., Vande Woude, G. F., and Aaronson, S. A. (1991) Science 251, 802-804 [Medline] [Order article via Infotrieve]
  11. Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., and Vande Woude, G. (1986) Cell 45, 895-904 [Medline] [Order article via Infotrieve]
  12. Rodrigues, G. A., Naujokas, M. A., and Park, M. (1991) Mol. Cell. Biol. 11, 2962-2970 [Medline] [Order article via Infotrieve]
  13. Gonzatti-Haces, M., Seth, A., Park, M., Copeland, T., Oroszlan, S., and Vande Woude, G. F. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 21-25 [Abstract]
  14. Naldini, L., Vigna, E., Ferracini, R., Longati, P., Gandino, L., Prat, L., and Comoglio, P. M. (1991) Mol. Cell. Biol. 11, 1793-1803 [Medline] [Order article via Infotrieve]
  15. Zhu, H., Naujokas, M. A., and Park, M. (1994) Cell Growth Differ. 5, 359-366 [Abstract]
  16. Weidner, K. M., Sachs, M., and Birchmeier, W. (1993) J. Cell Biol. 121, 145-154 [Abstract]
  17. Komada, M., and Kitamura, N. (1993) Oncogene 8, 2381-2390 [Medline] [Order article via Infotrieve]
  18. Zhu, H., Naujokas, M. A., Fixman, E. D., Torossian, K., and Park, M. (1994) J. Biol. Chem. 269, 29943-29948 [Abstract/Free Full Text]
  19. Weidner, K. M., Sachs, M., Riethmacher, D., and Birchmeier, W. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2597-2601 [Abstract]
  20. Pawson, T. (1995) Nature 373, 573-580 [CrossRef][Medline] [Order article via Infotrieve]
  21. Naldini, L., Vigna, E., Narsimhan, R. P., Gaudino, G., Zarnegar, R., Michalopoulos, G. A., and Comoglio, P. M. (1991) Oncogene 6, 501-504 [Medline] [Order article via Infotrieve]
  22. Park, M., Dean, M., Kaul, K., Braun, M. J., Gonda, M. A., and Vande Woude, G. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6379-6383 [Abstract]
  23. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G., and Comoglio, P. M. (1994) Cell 77, 261-271 [Medline] [Order article via Infotrieve]
  24. Songyang, Z., Shoelson, S. E., McGlade, J., Olivier, P., Pawson, T., Bustelo, X. R., Barbacid, M., Sabe, H., Hanafusa, H., Yi, T., Ren, R., Baltimore, D., Ratnofsky, S., Feldman, R. A., and Cantley, L. C. (1994) Mol. Cell. Biol. 14, 2777-2785 [Abstract]
  25. Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechlelder, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C. (1993) Cell 72, 767-778 [Medline] [Order article via Infotrieve]
  26. Fixman, E. D., Naujokas, M. A., Rodrigues, G. A., Moran, M. F., and Park, M. (1995) Oncogene 10, 237-249 [Medline] [Order article via Infotrieve]
  27. Fournier, T. M., Kamikura, D., Teng, K., and Park, M. (1996) J. Biol. Chem. 271, 22211-22217 [Abstract/Free Full Text]
  28. Pelicci, G., Giordano, S., Zhen, Z., Salcini, A. E., Lanfrancone, L., Bardelli, A., Panayotou, G., Waterfield, M. D., Ponzetto, C., Pelicci, P. G., and Comoglio, P. M. (1995) Oncogene 10, 1631-1638 [Medline] [Order article via Infotrieve]
  29. Fixman, E. D., Fournier, T. M., Kamikura, D. M., Naujokas, M. A., and Park, M. (1996) J. Biol. Chem. 271, 13116-13122 [Abstract/Free Full Text]
  30. Kamikura, D. M., Naujokas, M. A., and Park, M. (1996) Biochemistry 35, 1010-1017 [CrossRef][Medline] [Order article via Infotrieve]
  31. Smith, D. B., and Johnson, K. S. (1988) Gene 67, 31-40 [CrossRef][Medline] [Order article via Infotrieve]
  32. Cooper, J. A., Sefton, B. M., and Hunter, T. (1983) Methods Enzymol. 99, 387-402 [Medline] [Order article via Infotrieve]
  33. Cleveland, D. W., Fischer, S. G., Kirschner, M. W., and Laemmli, U. K. (1977) J. Biol. Chem. 252, 1102-1106 [Abstract]
  34. Morrison, D. K., Kaplan, D. R., Escobedo, J. A., Rapp Ulf, R., Roberts, T. M., and Williams, L. T. (1989) Cell 58, 649-657 [Medline] [Order article via Infotrieve]
  35. Cooper, J. A., and Hunter, T. (1981) Mol. Cell. Biol. 1, 165-178 [Medline] [Order article via Infotrieve]
  36. Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K., and Wong, A. J. (1996) Nature 379, 560-564 [CrossRef][Medline] [Order article via Infotrieve]
  37. Weidner, K. M., Dicesare, S., Sachs, M., Brinkmann, V., Behrens, J., and Birchmeier, W. (1996) Nature 384, 173-176 [CrossRef][Medline] [Order article via Infotrieve]
  38. Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., and White, M. F. (1991) Nature 352, 73-77 [CrossRef][Medline] [Order article via Infotrieve]
  39. Sun, X. J., Wang, L. M., Zhang, Y., Yenush, L., Myers, M. G., Jr., Glasheen, E., Lane, W. S., Pierce, J. H., and White, M. F. (1995) Nature 377, 173-177 [CrossRef][Medline] [Order article via Infotrieve]
  40. Raabe, T., Riesgo-Ecovar, J., Liu, X., Bausenwein, B. S., Deak, P., Maroy, P., and Hafen, E. (1996) Cell 85, 911-920 [Medline] [Order article via Infotrieve]
  41. Herbst, R., Carroll, P. M., Allard, J. D., Schilling, J., Raabe, T., and Simon, M. A. (1996) Cell 85, 899-909 [Medline] [Order article via Infotrieve]
  42. Lemmon, M. A., Ferguson, K. M., and Schlessinger, J. (1996) Cell 85, 621-624 [Medline] [Order article via Infotrieve]
  43. Derman, M. P., Cuha, M. J., Barros, E. J., Nigam, S. K., and Cantley, L. G. (1995) Am. J. Physiol. 268, F1211-F1217 [Abstract/Free Full Text]
  44. Royal, I., and Park, M. (1995) J. Biol. Chem. 270, 27780-27787 [Abstract/Free Full Text]
  45. Haugel-DeMouzon, S., Csermly, P., Zoppini, G., and Kahn, C. R. (1992) J. Cell Physiol. 150, 180-187 [Medline] [Order article via Infotrieve]
  46. Montesano, R., Schaller, G., and Orci, L. (1991) Cell 66, 697-711 [Medline] [Order article via Infotrieve]
  47. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.